.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
US Department of Justice
Federal Trade Commission
Cipla
Moodys
Dow
Covington
Fuji
Queensland Health

Generated: December 16, 2017

DrugPatentWatch Database Preview

TENORETIC 50 Drug Profile

« Back to Dashboard

Which patents cover Tenoretic 50, and what generic alternatives are available?

Tenoretic 50 is a drug marketed by Alvogen Malta and is included in one NDA.

The generic ingredient in TENORETIC 50 is atenolol; chlorthalidone. There are thirty-three drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
Drug patent expirations by year for TENORETIC 50

Pharmacology for TENORETIC 50

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen MaltaTENORETIC 50atenolol; chlorthalidoneTABLET;ORAL018760-002Jun 8, 1984ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TENORETIC 50

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen MaltaTENORETIC 50atenolol; chlorthalidoneTABLET;ORAL018760-002Jun 8, 1984► Subscribe► Subscribe
Alvogen MaltaTENORETIC 50atenolol; chlorthalidoneTABLET;ORAL018760-002Jun 8, 1984► Subscribe► Subscribe
Alvogen MaltaTENORETIC 50atenolol; chlorthalidoneTABLET;ORAL018760-002Jun 8, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Fuji
AstraZeneca
Federal Trade Commission
Julphar
Novartis
Queensland Health
Fish and Richardson
Merck
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot